All filters
Slidesets
Prof. Charles Boucher Memorial Lecture: The Story of Hepatitis C: Translating Science to Clinical Reality - Harvey J. Alter, MD, MACP
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Meeting Report
Meeting Report Day 3 | V. Bukkems | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 2 | J. Castillo-Mancilla | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | N. Thakkar | | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | V. Bukkems | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | M. Ferrara | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | S. Khoo | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | N. Sheehan | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | L. Walker | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | D. Hodge | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Abstracts
Key Considerations for the Introduction of Hepatitis B Birth Dose Vaccine in Cameroon
D. Kamga
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
A Community of Practice for the Introduction and Scale-up of Hepatitis B Birth Dose Vaccination in Africa: Challenges, Opportunities, and Lessons Learned
H. Njuguna
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Hépatite Delta au Senegal
M. Balkissa
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Long Term Follow up of Chronic Hepatitis B Cohort in Africa; The Prolifica Gambia Exprience
I. Mahmoud
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Assessment of Fibrosis Markers in HEPSANET: A Collaborative Network of Hepatitis B Cohorts in Sub-Saharan Africa
A. Johannessen
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Age Cohort Screening for Hepatocellular Carcinoma in an African Population
J. Makpu
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Velpatasvir-Based Regimens in Treatment-Naïve and Treatment-Experienced Adults with Resistant Hepatitis C Virus Genotype 4 Subtypes Endemic to Sub-Saharan Africa: Findings from the SHARED-3 Study in Rwanda
F. Shumbusho
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Values and Preferences for Hepatitis C Self-Testing Among the General Population and Healthcare Workers in Rwanda
J. Serumondo
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
EILF-Italian Migrants Study: an HCV and HBV Micro Elimination Pilot Project
G. Colucci
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Genedrive® Point of Care Qualitative Testing in a Pilot Hepatitis C Treatment Program
V. Hechter
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021